are classified in class A (bla KPC vb.), B (bla VIM-1 , bla IMP , bla NDM-1 vb.) and D (bla OXA-48 vb.) according to the Ambler classification (3, 4) . Phenotypic determination of carbapenem-producing Enterobacteriaceae members is difficult because carbapenems' minimum inhibitory concentrations may be low. Therefore, the genotypic determination of carbapenemase producing genes is gold standard (5) .
In this study, we aimed to evaluate the carbapenem resistance in Klebsiella pneumoniae (K. pneumoniae)strains, the identification of resistance genes that cause this resistance, and the clonal relationship between resistant strains.
Methods

Bacterial Strains
Ninety one strains resistant to carbapenem among 2903 K. pneumoniae strains isolated in our hospital microbiology laboratory between January 2015 and December 2016 were included in this study. The identification of bacteria was made with Matriks assisted laser desorption ionization time of flight mass spectrometry (bioMérieux, Marcy-I'Etoile, France). İstanbul Medeniyet University Göztepe Training and Research Hospital Clinical Research Ethics Committee decision no: 2016/0034, 09.02.201.
Antimicrobial Susceptibility Testing
Antimicrobial susceptibility test of isolated strains (colistin, ampicillin/sulbactam, piperacilin/tazobactam, ceftazidime, ceftriaxone, erapenem, meropenem, imipenem, ciprofloxacin, levofloxacin, gentamicin, amikacin and trimethoprim/ sulfamethoxazole) was done with the automated system of VITEK-2 (bioMérieux, Marcy-I'Étoile, France). The authentication of strains with decreased sensitivity or resistance to any of the carbapenems was performed with erythromycin E-test (bioMérieux). Border values were evaluated in accordance with the recommendations of European Committee on Antimicrobial Susceptibility Testing (EUCAST) (6). K. pneumoniae American Type Culture Collection (ATCC) 700603 was used as the quality control strain.
Investigation of the Genes that Produce Carbapenemase
DNA extraction was carried out using the Qiagen (QIA)mp DNA mini kit (Qiagen GmbH, Hilden, Germany) in 18-24-hour culture of bacteria in accordance with the recommendations of the manufacturer. The genes causing carbapenemase production (bla OXA-48 , bla NDM-1 , bla KPC , bla IMP , bla VIM-1 ) were evaluated with real-time polymerase chain reaction (PCR) in the Rotor-Gene Q device (Qiagen, Germany). The presence of the genes evaluated in the study was investigated using commercially produced Microbial DNA qPCR Assay (REF 330025) (Qiagen, USA) kits. Data obtained from PCR results were analyzed by setting the green channel threshold to 0.02 absolute value.
Pulsed-field Gel Electrophoresis (PFGE)
The epidemiological relation of carbapenem resistant K. pneumoniae (KDKp) strains was investigated in the the Molecular Microbiology Laboratory of Turkish Public Health Institution using pulsed-field gel electrophoresis (PFGE). Bionumerics program 7.1 version was used to evaluate the results. Clustering analysis was performed using "unwighted pair group method with mathematical averaging". The relationship between the strains was determined according to "dice" similarity coefficient. Tolerance was taken as 1.5% and optimization as 1% in the calculation of similarity coefficient. PFGE types were determined according to the DNA tailing patterns, in accordance with the criteria defined by Tenover et al. (7) and the strains with a similarity of ≥85% were defined as "related strains". Normalization was done by using K. pneumoniae ATCC 700603 standard strain.
Results
Ninety-one (3.13%) of a total of 2903 K. pneumoniae strains isolated from various clinical samples in our laboratory were found to be resistant to at least one antimicrobial agent from carbapenem group.
Of carbapenem resistant strains, 49.5% were isolated from intensive care unit, 12.1% from internal medicine, 11% from general surgery, 8.8% from brain surgery and 8.8% from child health and disease services and 9.8% from other services (emergency service, infectious diseases, neurology and urology). Of resistant strains, 58.2% were isolated from blood, 19.8% from tracheal aspirate, 11% from deep tissue aspirate, 8.8% from urine and 2.2% from phlegm culture. All strains were resistant to ertapenem, 93.3% to meropenem, 91.1% to imipenem. In addition, all KDKp strains were resistant to piperacillin/ tazobactam and ampicillin/sulbactam, 95.6% to ceftazidime and ceftriaxon, 86.7% to ciprofloxacin and levofloxacin, 82.2% to trimethoprim/sulfamethoxazole. Resistance rates to colistin, amikacin and gentamicin were shown as 9%, 42.2% and 62.2%, respectively and they were relatively sensitive antibiotics.
All strains were tested for bla OXA-48 , bla NDM-1 , bla KPC , bla IMP and bla VIM-1 resistance genes, and bla OXA-48 (55%) and bla NDM-1 (37.4%) were the most frequently found resistance genes ( Figure  1 ). Resistance genes were not detected in a total of 15 strains and two different resistance genes were found in 10 strains.
Seventy three of 91 KDKp strains included in the study were investigated in terms of clonal relations with PFGE due to the technical problems experienced in the reanimation of bacteria. In (Figure 2 ). The presence of K. pneumoniae strains carrying the same resistance genes in different groups suggested that mobile genetic elements carrying these resistance genes might be transferred horizontally.
Discussion
Carbapenem resistance has been spreading rapidly recently and is a major problem threatening public health. The solution of this problem requires studies to explain the mechanisms of resistance and the development of methods to determine the resistance to carbapenem quickly and easily (3, 8) .
EUCAST indicates that ertapenem has high sensitivity and low specificity and meropenem has good sensitivity-specificity balance in detecting carbapenem resistance in Enterobacteriaceae (9). Therefore, in our study, ertapenem E-test was used to confirm carbapenem resistance. All strains were resistant to ertapenem and some strains were resistant to both meropenem and imipenem. Our findings supported that the use of ertapenem in detection of carbapenem resistance was more appropriate.
In the multi-center SENTRY study conducted in the United States (USA) between 2007-2009, carbapenem resistance in K.
pneumoniae strains was found to be 6.1% (10) . This resistance was 1-5% in the European Antimicrobial Resistance Surveillance System-2008 study in Europe and 3.2% in the high ıntensity tactical training-2 study in Turkey (11, 12) . Karbapenem resistance was found 3.13% in our study, consistent with the European and Turkish Data.
KDKp strains were most frequently isolated from intensive care units, compatible with another study in our country (3) . Mechanical ventilation, prolonged intubation time, the use of paralytic agents and advanced age were found to increase the risk of infection. Even staying in the intensive care unit was stated as a risk factor alone (13) .
All of the strains undergoing antimicrobial susceptibility test performed with KDKp strains were reported to be resistant to ertapenem. The most sensitive antimicrobial was reported as colistin (3, 14) . The data we obtained in our study showed the same situation.
Carbapenemase resistance was first identified in Enterobacter clocae strains more than 20 years ago. During this time, a large number of carbapenem resistance has been reported in different bacteria with different resistance mechanisms from many countries of the world (15) .
In the present study, we found that bla OXA-48 and bla NDM-1 were the most frequent carbapenem resistance genes (55% and 37.4%, respectively). K. pneumoniae strains carrying bla OXA-48 are considered endemic in Turkey (3, 16, 17) . In a multi-center study conducted in Europe, K. pneumoniae strains with decreased sensitivity to carbapenem with bla OXA-48 positivity was found to be 79% for Turkey (18) . Tekintaş et al. (19) showed bla OXA-48 positivity in 52 of 54 (96.3%) KDKp strains in a study published in 2017.
An endemic region for bla NDM-1 positive K. pneumoniae has not been identified It was seen in Sweden in 2015 and it was isolated from a patient in India in 2009 (17, 20) . Bla NDM-1 positivity in carbapenem resistant K. pneumoniae strains was detected in 2011 for the first time in Turkey in a patient with leukemia who underwent a bone marrow transplantation (3). In a multicenter study published in 2017, bla NDM-1 positivity was reported as 7.3% in KDKp strains in Turkey (18) . Other studies in our country reported bla NDM-1 positivity in 38.9% and 29.5% of strains (19, 21) . These ratios coincide with our findings.
In our study, bla KPC and bla VIM-1 genes were detected in one patient and bla IMP gene was not detected. The presence of bla IMP, bla VIM-1 and bla KPC in K. pneumoniae strains in Turkey was first detected in 2003, 2005 and 2014, respectively (22) (23) (24) . In a study conducted in our country in 2016, only one of 279 KDKp strains was found to have bla IMP gene (25) . These genes are endemic in some countries such as Italy and Greece (15, 17) . In our study, resistance genes other than the five most common carbapenemase enzymes in Turkey were not searched, which constituted the limitation of our study. PFGE patterns of a total of 73 KDKp strains showed differences. Although isolating times of strains in group 1 were close to each other, the services they were isolated were different. Being isolated of the strains in groups 2, 7, 9, 11 and 15 at different times from the same service suggested that a health worker or material might be a reservoir. In other groups, it was observed that the strains were isolated in services at different times from each other. K. pneumoniae strains carrying the same resistance gene could be found in different groups or even they did not belong to any group, suggesting that mobile genetic elements carrying these resistance genes might be transferred horizontally between bacteria.
Conclusion
As a result, carbapenem resistance in our country is not yet at the highest level. This was found to be 3.13% in our study. However, the horizontal spread of the genes that cause carbapenem resistance can be a major problem in the near future. Because of the more deadly surveillance of infections with KDKp strains and the lack of treatment options; rapid and reliable tests are needed to determine resistance status (26) (27) (28) . Although the molecular methods in detection of carbapenemase are gold standard, they can not be done routinely in each laboratory because of the high cost. Alternatively, practical and less costly methods such as carbapenemase inactivation test or modified hodge test can be used in the determination carbapenemase.
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